Lin28 regulates HER2 and promotes malignancy through multiple mechanisms

Chen Feng, Veronique Neumeister, Wei Ma, Jie Xu, Lingeng Lu, Jennifer Bordeaux, Nita Jane Maihle, David L. Rimm, Yingqun Huang

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The RNA binding protein Lin28 and its paralog Lin28B are associated with advanced human malignancies. Blocking the biogenesis of let-7 miRNA, a tumor suppressor, by Lin28/Lin28B has been thought to underlie their roles in cancer. Here we report that the mRNA for the human epidermal growth factor receptor 2 (HER2), a HER-family receptor tyrosine kinase known to play a critical role in cell proliferation and survival and also a major therapeutic target in breast cancer, is among several targets of Lin28 regulation. We show that Lin28 stimulates HER2 expression at the posttranscriptional level, and that enforced Lin28 expression promotes cancer cell growth via multiple mechanisms. Consistent with its pleiotropic role in regulating gene expression, Lin28 overexpression in primary breast tumors is a powerful predictor of poor prognosis, representing the first report on the impact of Lin28 expression on clinical outcome in human cancer. While revealing another layer of regulation of HER2 expression in addition to gene amplification, our studies also suggest novel mechanistic insights linking Lin28 expression to disease outcome and imply that targeting multiple pathways is a common mechanistic theme of Lin28-mediated regulation in cancer.

Original languageEnglish (US)
Pages (from-to)2486-2494
Number of pages9
JournalCell Cycle
Volume11
Issue number13
DOIs
StatePublished - Jul 1 2012

Fingerprint

Neoplasms
Breast Neoplasms
RNA-Binding Proteins
Gene Amplification
MicroRNAs
Protein-Tyrosine Kinases
human ERBB2 protein
Cell Survival
Cell Proliferation
Gene Expression
Messenger RNA
Growth
Therapeutics
ErbB Receptors

Keywords

  • Breast cancer
  • Her2 (ErbB2/neu)
  • Lin28
  • Post-transcriptional

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Cite this

Feng, C., Neumeister, V., Ma, W., Xu, J., Lu, L., Bordeaux, J., ... Huang, Y. (2012). Lin28 regulates HER2 and promotes malignancy through multiple mechanisms. Cell Cycle, 11(13), 2486-2494. https://doi.org/10.4161/cc.20893

Lin28 regulates HER2 and promotes malignancy through multiple mechanisms. / Feng, Chen; Neumeister, Veronique; Ma, Wei; Xu, Jie; Lu, Lingeng; Bordeaux, Jennifer; Maihle, Nita Jane; Rimm, David L.; Huang, Yingqun.

In: Cell Cycle, Vol. 11, No. 13, 01.07.2012, p. 2486-2494.

Research output: Contribution to journalArticle

Feng, C, Neumeister, V, Ma, W, Xu, J, Lu, L, Bordeaux, J, Maihle, NJ, Rimm, DL & Huang, Y 2012, 'Lin28 regulates HER2 and promotes malignancy through multiple mechanisms', Cell Cycle, vol. 11, no. 13, pp. 2486-2494. https://doi.org/10.4161/cc.20893
Feng C, Neumeister V, Ma W, Xu J, Lu L, Bordeaux J et al. Lin28 regulates HER2 and promotes malignancy through multiple mechanisms. Cell Cycle. 2012 Jul 1;11(13):2486-2494. https://doi.org/10.4161/cc.20893
Feng, Chen ; Neumeister, Veronique ; Ma, Wei ; Xu, Jie ; Lu, Lingeng ; Bordeaux, Jennifer ; Maihle, Nita Jane ; Rimm, David L. ; Huang, Yingqun. / Lin28 regulates HER2 and promotes malignancy through multiple mechanisms. In: Cell Cycle. 2012 ; Vol. 11, No. 13. pp. 2486-2494.
@article{546a121475644f33b417b93cf6b05d56,
title = "Lin28 regulates HER2 and promotes malignancy through multiple mechanisms",
abstract = "The RNA binding protein Lin28 and its paralog Lin28B are associated with advanced human malignancies. Blocking the biogenesis of let-7 miRNA, a tumor suppressor, by Lin28/Lin28B has been thought to underlie their roles in cancer. Here we report that the mRNA for the human epidermal growth factor receptor 2 (HER2), a HER-family receptor tyrosine kinase known to play a critical role in cell proliferation and survival and also a major therapeutic target in breast cancer, is among several targets of Lin28 regulation. We show that Lin28 stimulates HER2 expression at the posttranscriptional level, and that enforced Lin28 expression promotes cancer cell growth via multiple mechanisms. Consistent with its pleiotropic role in regulating gene expression, Lin28 overexpression in primary breast tumors is a powerful predictor of poor prognosis, representing the first report on the impact of Lin28 expression on clinical outcome in human cancer. While revealing another layer of regulation of HER2 expression in addition to gene amplification, our studies also suggest novel mechanistic insights linking Lin28 expression to disease outcome and imply that targeting multiple pathways is a common mechanistic theme of Lin28-mediated regulation in cancer.",
keywords = "Breast cancer, Her2 (ErbB2/neu), Lin28, Post-transcriptional",
author = "Chen Feng and Veronique Neumeister and Wei Ma and Jie Xu and Lingeng Lu and Jennifer Bordeaux and Maihle, {Nita Jane} and Rimm, {David L.} and Yingqun Huang",
year = "2012",
month = "7",
day = "1",
doi = "10.4161/cc.20893",
language = "English (US)",
volume = "11",
pages = "2486--2494",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "13",

}

TY - JOUR

T1 - Lin28 regulates HER2 and promotes malignancy through multiple mechanisms

AU - Feng, Chen

AU - Neumeister, Veronique

AU - Ma, Wei

AU - Xu, Jie

AU - Lu, Lingeng

AU - Bordeaux, Jennifer

AU - Maihle, Nita Jane

AU - Rimm, David L.

AU - Huang, Yingqun

PY - 2012/7/1

Y1 - 2012/7/1

N2 - The RNA binding protein Lin28 and its paralog Lin28B are associated with advanced human malignancies. Blocking the biogenesis of let-7 miRNA, a tumor suppressor, by Lin28/Lin28B has been thought to underlie their roles in cancer. Here we report that the mRNA for the human epidermal growth factor receptor 2 (HER2), a HER-family receptor tyrosine kinase known to play a critical role in cell proliferation and survival and also a major therapeutic target in breast cancer, is among several targets of Lin28 regulation. We show that Lin28 stimulates HER2 expression at the posttranscriptional level, and that enforced Lin28 expression promotes cancer cell growth via multiple mechanisms. Consistent with its pleiotropic role in regulating gene expression, Lin28 overexpression in primary breast tumors is a powerful predictor of poor prognosis, representing the first report on the impact of Lin28 expression on clinical outcome in human cancer. While revealing another layer of regulation of HER2 expression in addition to gene amplification, our studies also suggest novel mechanistic insights linking Lin28 expression to disease outcome and imply that targeting multiple pathways is a common mechanistic theme of Lin28-mediated regulation in cancer.

AB - The RNA binding protein Lin28 and its paralog Lin28B are associated with advanced human malignancies. Blocking the biogenesis of let-7 miRNA, a tumor suppressor, by Lin28/Lin28B has been thought to underlie their roles in cancer. Here we report that the mRNA for the human epidermal growth factor receptor 2 (HER2), a HER-family receptor tyrosine kinase known to play a critical role in cell proliferation and survival and also a major therapeutic target in breast cancer, is among several targets of Lin28 regulation. We show that Lin28 stimulates HER2 expression at the posttranscriptional level, and that enforced Lin28 expression promotes cancer cell growth via multiple mechanisms. Consistent with its pleiotropic role in regulating gene expression, Lin28 overexpression in primary breast tumors is a powerful predictor of poor prognosis, representing the first report on the impact of Lin28 expression on clinical outcome in human cancer. While revealing another layer of regulation of HER2 expression in addition to gene amplification, our studies also suggest novel mechanistic insights linking Lin28 expression to disease outcome and imply that targeting multiple pathways is a common mechanistic theme of Lin28-mediated regulation in cancer.

KW - Breast cancer

KW - Her2 (ErbB2/neu)

KW - Lin28

KW - Post-transcriptional

UR - http://www.scopus.com/inward/record.url?scp=84863808561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863808561&partnerID=8YFLogxK

U2 - 10.4161/cc.20893

DO - 10.4161/cc.20893

M3 - Article

C2 - 22713243

AN - SCOPUS:84863808561

VL - 11

SP - 2486

EP - 2494

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 13

ER -